Product Detail
Warfarin potassium
Warfarin API
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
API
API Family
Warfarin
Storage
2-8°C
Hazard Information
Refer MSDS for complete information.
Warfarin potassium Product Information
Warfarin potassium is listed under API. It is associated with Warfarin and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-02587.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Warfarin potassium
CAS No.
2610-86-8
CAT No.
CS-O-02587
Molecular Formula
C19H16 O4 . K
Molecular Weight
346.44
Category
API Family
Storage Condition
2-8°C
SMILES
CC(CC(C1=C([O-])C2=CC=CC=C2OC1=O)C3=CC=CC=C3)=O.[K+]
IUPAC Name
potassium 2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-4-olate
Purity by HPLC
>98%
Hazard Compound
Refer MSDS for complete information.
Description
Overview
"Warfarin potassium is an anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibr"
Synonyms
2H-1-Benzopyran-2-one;4-hydroxy-3-(3-oxo-1-phenylbutyl); potassium salt (cI);coumarin; 3-(a-cetonylbenzyl)-4-hydroxy;potassium salt (cI); Potassium; [[3-(a-cetonylbenzyl)-2-oxo-2H-1-benzopyran-4-yl]oxy]-(cI); Antrombin K; Potassium 3-(a-cetonylbenzyl)-4-hydroxcoumarin; Potassium warfarin; Warfarin K;Warfarin potassium
Application Notes
"Warfarin potassium is an anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibr"
References
"Hagan; Ec,; et al,: J, Am, Pharm, Assc, ci, Ed,; 42; 379 (1953); Bell; R,G,; et al,: Bichemistry; 11; 1959 (1972); Valente; J,E,; et al,: J, Med,chem,; 20; 1489 (1977); Bck; N,; et al,: Pharmcol, Res,commun,; 10; 445; (1978); Babhair; S,A,; et al,"
